raloxifene peptide limits TDP-25 cell death - rapamycin-peptide raloxifene-paper-peptide-figure-notebook Understanding Raloxifene Peptide: A Comprehensive Exploration

mimotope-peptide Raloxifene peptide is a term that emerges in scientific literature and research contexts, often related to the study and application of the drug raloxifene. Raloxifene itself is a well-established pharmaceutical agent, primarily known for its role in managing menopausal health and preventing certain diseasesRaloxifene Related Compound C (20 mg) (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate). When the term "peptide" is associated with raloxifene, it can refer to several aspects, including its molecular interactions, its use in research involving peptide analysis, or potentially novel delivery systems.Raloxifene hydrochloride is a selective estrogen receptor modulator(SERM) that binds to ERα and ERβ, and tissue-dependently activates or blocks estrogen- ... This article delves into the multifaceted nature of raloxifene and its connection to peptides, drawing upon scientific understanding and E-E-A-T principles to provide a thorough overview.

Raloxifene: A Selective Estrogen Receptor Modulator (SERM)

At its core, raloxifene (often found as raloxifene hydrochloride) is a selective estrogen receptor modulator (SERM). This classification means that it can act like estrogen in some parts of the body while blocking estrogen's effects in others. This tissue-specific activity is crucial to its therapeutic benefits. For instance, raloxifene has estrogen-agonistic effects on bone and lipids, meaning it mimics estrogen's positive influence on bone density and cholesterol levelsraloxifeneis an approved drug (FDA (1997), EMA (1998)) Compound class: Synthetic organic Comment:Raloxifeneis a selective estrogen receptor modulator (SERM).. Conversely, raloxifene acts as an antagonist on estrogen receptors in breast and uterus, which is beneficial in reducing the risk of certain cancers.Raloxifeneis clinically used to prevent osteoporosis in post-menopausal womenand to treat ER+ breast cancer. This compound exhibits anti-osteoporotic, anti- ...

The U.S.Raloxifene acts as an antagonist on estrogen receptors in breast and uterusbut shows estrogenic effects on bone, cholesterol metabolism, and brain. 20 1. Both ... Food and Drug Administration (FDA) approved raloxifene in 1997, leading to its introduction under brand names like EvistaRaloxifene - an overview | ScienceDirect Topics. Its primary indications include the prevention and treatment of osteoporosis in postmenopausal women. By binding to estrogen receptors, specifically ERα and ERβ, raloxifene increases bone mineral density in postmenopausal women, thereby reducing the risk of vertebral fracturesRaloxifene - an overview | ScienceDirect Topics. This makes it a vital medication for maintaining skeletal health during and after menopause2024年1月21日—Raloxifene, sold under the brand name Evista among others,is a medication used to prevent and treat osteoporosis in postmenopausal women....

Beyond osteoporosis, raloxifene is clinically used to prevent osteoporosis in post-menopausal women and to treat ER+ breast cancer.Buy Raloxifene 50mg, 1000 Tablets - 0 | SERM - QSC Its anti-estrogenic effects on breast tissue contribute to this reduced cancer risk. Research has also explored its potential in other areasRaloxifene - StatPearls - NCBI Bookshelf - NIH. For example, studies suggest raloxifene safeguards against Aβo-induced neurotoxicity, indicating a potential neuroprotective potential of raloxifene via G-protein-coupled receptors. This area of research is ongoing, with findings suggesting it may modify oxidative parameters and maintain intracellular calcium homeostasis.

The "Peptide" Connection: Research and Analysis

The inclusion of "peptide" in "raloxifene peptide" often points to its presence in scientific research, particularly in areas involving molecular interactions and analytical techniques. For instance, a raloxifene-paper-peptide-figure-notebook suggests computational or experimental work where raloxifene is analyzed in conjunction with peptidesRaloxifene Hydrochloride. This could involve studies examining how raloxifene interacts with specific peptide sequences or how peptide-based analytical methods are used to study raloxifene itself.

Furthermore, some research investigates the binding profiles of compounds like raloxifene with LXXLL cofactor peptides. These studies aim to understand the molecular mechanisms by which SERMs exert their effectsRaloxifene hydrochloride is a selective estrogen receptor modulator(SERM) that binds to ERα and ERβ, and tissue-dependently activates or blocks estrogen- .... Findings indicate that both tamoxifen and raloxifene induce very similar peptide profiles, shedding light on shared or distinct modes of action.

The term can also appear in the context of laboratory reagentsRaloxifene - StatPearls - NCBI Bookshelf - NIH. For example, one might find listings for Raloxifene 60mg per ml x 30ml | For Laboratory Use Only from suppliers specializing in research chemicals, including peptide synthesis and analysis. This emphasizes that such products are intended for scientific investigation, not human consumption. The presence of Magnum Raloxifene 471.15 adduct PSMs in scientific databases points to advanced mass spectrometry techniques used to identify and quantify raloxifene and its related compounds, often in complex biological samples.

Emerging Research and Future Directions

While raloxifene is an established drug, research continues to explore its potential and refine its applications. Novel delivery systems for raloxifene hydrochloride are being investigated, aiming to improve its efficacy or reduce side effectsRaloxifene hydrochloride. This could involve nano-formulations or other advanced pharmaceutical technologies.

The exploration of raloxifene's interaction with cellular pathways, as seen in studies suggesting it limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis, highlights its complex biological effects beyond its primary indications. These findings could lead to new therapeutic avenues for conditions involving protein aggregation and cell death.

In summary, raloxifene peptide generally refers to the drug raloxifene within a research or analytical context involving peptides.Raloxifene is an oral selective estrogen receptor modulator(SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. As a SERM, raloxifene plays a significant role in women's health, offering benefits for bone density and reducing breast cancer risk. Ongoing research continues to unravel its intricate mechanisms of action and explore its broader therapeutic potential, often utilizing peptide-related scientific methodologies.